OAM
MYOV

Oxford Asset Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Oxford Asset Management’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-101,616
Closed -$1.58M – 1499
2019
Q4 		$1.58M Buy
+101,616
New +$1.02M 0.04% 569
2018
Q1 		– Sell
-13,774
Closed -$175K – 1960
2017
Q4 		$175K Sell
13,774
-11,668
-46% -$156K ﹤0.01% 1470
2017
Q3 		$393K Sell
25,442
-4,303
-14% -$52.3K 0.01% 1272
2017
Q2 		$348K Buy
29,745
+3,971
+15% +$49.2K 0.01% 1217
2017
Q1 		$303K Buy
+25,774
New +$295K 0.01% 1198

Other funds holding MYOV

Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NCM
NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Oxford Asset Management's MYOV Position: Q1 2020 in Review

Oxford Asset Management sold out of Myovant Sciences Ltd. (MYOV) in Q1 2020, closing a stake of 101,616 shares — an estimated $1.58M sold.

Oxford Asset Management first reported a position in MYOV in Q1 2017 and held it in 5 quarters. The position peaked at $1.58M in Q4 2019. 75 funds tracked by Wall St. Rank hold MYOV as of Q1 2020.

  • Oxford Asset Management reported no remaining Myovant Sciences Ltd. position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 101,616 Myovant Sciences Ltd. shares in Q1 2020, an estimated $1.58M.
  • Oxford Asset Management first reported a position in Myovant Sciences Ltd. in Q1 2017 and held it in 5 quarters.
  • Oxford Asset Management's Myovant Sciences Ltd. position peaked at $1.58M in Q4 2019.
  • 75 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.